DE602005003817D1 - Mittels botulinumtoxin a (bont/a) erkennbare peptidsubstrate und verwendung - Google Patents

Mittels botulinumtoxin a (bont/a) erkennbare peptidsubstrate und verwendung

Info

Publication number
DE602005003817D1
DE602005003817D1 DE602005003817T DE602005003817T DE602005003817D1 DE 602005003817 D1 DE602005003817 D1 DE 602005003817D1 DE 602005003817 T DE602005003817 T DE 602005003817T DE 602005003817 T DE602005003817 T DE 602005003817T DE 602005003817 D1 DE602005003817 D1 DE 602005003817D1
Authority
DE
Germany
Prior art keywords
bont
botulinum toxin
peptide substrate
detectable peptide
fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005003817T
Other languages
English (en)
Other versions
DE602005003817T2 (de
Inventor
Marie-Claude Fournie-Zaluski
Bernard Pierre Roques
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmaleads SA
Original Assignee
Pharmaleads SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0404817A external-priority patent/FR2869908B1/fr
Application filed by Pharmaleads SA filed Critical Pharmaleads SA
Publication of DE602005003817D1 publication Critical patent/DE602005003817D1/de
Application granted granted Critical
Publication of DE602005003817T2 publication Critical patent/DE602005003817T2/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Photometry And Measurement Of Optical Pulse Characteristics (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE602005003817T 2004-05-05 2005-05-04 Mittels botulinumtoxin a (bont/a) erkennbare peptidsubstrate und verwendung Active DE602005003817T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR0404817A FR2869908B1 (fr) 2004-05-05 2004-05-05 Substrat peptidique reconnu par la toxine botulique de type a, bont/a et son utilisation pour detecter et/ou doser ladite toxine ou des inhibiteurs de son activite
FR0404817 2004-05-05
FR0501435 2005-02-11
FR0501435 2005-02-11
PCT/FR2005/001121 WO2005121354A2 (fr) 2004-05-05 2005-05-04 Substrats peptidiques reconnus par la toxine botulique de type a, bont/a et leurs utilisations

Publications (2)

Publication Number Publication Date
DE602005003817D1 true DE602005003817D1 (de) 2008-01-24
DE602005003817T2 DE602005003817T2 (de) 2008-12-04

Family

ID=35503734

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005003817T Active DE602005003817T2 (de) 2004-05-05 2005-05-04 Mittels botulinumtoxin a (bont/a) erkennbare peptidsubstrate und verwendung

Country Status (8)

Country Link
US (1) US7875436B2 (de)
EP (1) EP1743034B1 (de)
AT (1) ATE380880T1 (de)
CA (1) CA2565678C (de)
DE (1) DE602005003817T2 (de)
ES (1) ES2297742T3 (de)
IL (1) IL179035A (de)
WO (1) WO2005121354A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8022172B2 (en) * 2001-08-28 2011-09-20 Allergan, Inc. Luminescence resonance energy transfer (LRET) assays for clostridial toxin activity
US7374896B2 (en) * 2001-08-28 2008-05-20 Allergan, Inc. GFP-SNAP25 fluorescence release assay for botulinum neurotoxin protease activity
EP1920248B1 (de) 2005-04-05 2010-09-29 Allergan, Inc. Clostridientoxinaktivitätstests
PT1869459E (pt) 2005-04-05 2010-08-10 Allergan Inc Ensaios fret à base de corantes lipofílicos para a actividade da toxina de clostrídeo
US8753831B2 (en) * 2007-06-05 2014-06-17 City Of Hope Methods for detection of botulinum neurotoxin
FR2931151A1 (fr) * 2008-05-13 2009-11-20 Pharmaleads Soc Par Actions Si Nouveaux derives d'amino-acides, leur procede de preparation et leur utilisation therapeutique
FR2963022B1 (fr) * 2010-07-21 2012-08-31 Pharmaleads Nouveaux substrats a fluorescence reprimee, leur preparation et leur utilisation pour l'identification, la detection et le dosage de legionella pneumophila
FR2997081B1 (fr) 2012-10-23 2015-11-27 Pharmaleads Inhibiteurs mixtes de l'aminopeptidase n et de la neprilysine
WO2015088477A1 (en) * 2013-12-09 2015-06-18 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Peptide substrates recognizable by type e botulinum neurotoxin
MX2019002835A (es) 2016-09-13 2019-09-04 Allergan Inc Composiciones no proteínicas de toxina clostridial.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2809733B1 (fr) * 2000-06-02 2004-04-30 Inst Nat Sante Rech Med Substrat peptidique reconnu par la toxine botulique de type bont/b et son utilisation pour doser et/ou detecter ladite toxine ou des inhibiteurs correspondants

Also Published As

Publication number Publication date
DE602005003817T2 (de) 2008-12-04
CA2565678A1 (fr) 2005-12-22
ATE380880T1 (de) 2007-12-15
WO2005121354A3 (fr) 2006-03-23
ES2297742T3 (es) 2008-05-01
US20090208993A1 (en) 2009-08-20
IL179035A (en) 2010-12-30
WO2005121354A2 (fr) 2005-12-22
EP1743034B1 (de) 2007-12-12
IL179035A0 (en) 2007-03-08
EP1743034A2 (de) 2007-01-17
US7875436B2 (en) 2011-01-25
CA2565678C (fr) 2013-07-09

Similar Documents

Publication Publication Date Title
DE602005003817D1 (de) Mittels botulinumtoxin a (bont/a) erkennbare peptidsubstrate und verwendung
TW200722681A (en) Illuminating device
DE602007003410D1 (de) Datenschutzgerechte Verknüpfung von Zeichenfolgen
NO20061722L (no) Nye GLP-1 derivater
NO20074604L (no) Fremgangsmate for optimering av drift av flere kompressoraggregater og tilsvarende anordning
ATE501204T1 (de) Klebstoffzusammensetzungen
ATE504620T1 (de) Polydiorganosiloxan-polyoxamid-copolymere
EA200701053A1 (ru) Продукт конъюгации
BRPI0513149A (pt) uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas substituìdas no tratamento de náuseas e vÈmito
ATE496516T1 (de) Elektronisches gerät zum ansteuern von led-ketten
DE60317674D1 (de) Selektive Tastaturbeleuchtung
ATE446536T1 (de) Motorsteuerungsmodul und -verfahren zur verwendung in der motorsystemherstellung
DK1738025T3 (da) Fibrøse strukturer omfattende en overfladebehandlende sammensætning og en lotionsammensætning
EP1486549A4 (de) Organisches elektrolumineszierendes element
ATE450588T1 (de) Triazolderivate und verwendung von triazolderivaten in organischen leuchtdioden (oleds)
ATE430551T1 (de) Kosmetische zusammensetzung enthaltend einen sulfonierten polyester und ein guargummiderivat
DE502005005521D1 (de) Wahlfreies Logging
DE602005013530D1 (de) Dentalkleberzusammensetzung
NL1022083A1 (nl) Scherminrichting, profiel en kas waarin zulks is toegepast.
ITRM20020140U1 (it) Mobile per tastiera musicale elettronica.
TW200611596A (en) Electrode, electrode substrate and organic electroluminescent apparatus
UA2603U (uk) Пристрій для остеосинтезу з z-подібним демпфером
TW200420454A (en) Display mirror
BR8202861Y1 (pt) disposição construtiva introduzida em mecanismo de acionamento de teclas.
BR8202927Y1 (pt) disposiÇço introduzida em ponteira com led para fotopolimerizaÇço.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition